DeepLife
DeepLife is a biotech innovator using AI and single-cell omics data to accelerate drug development and provide disease-specific insights to researchers and pharmaceutical companies. By creating digital twins of cells and leveraging multi-omics data, DeepLife aims to streamline drug development and bring lab breakthroughs closer to patient care.
Date, time and room information
May 6, 13:15 - 13:30, room Osaka/Samarkand
Category
Commercial stage company
Title of the presentation
Digital twin of cells for drug development
Speaker information
| Name | Position | Institution |
|---|---|---|
| Jonathan Baptista | Co-founder & CEO |
